Literature DB >> 6311825

Thrombin receptors define responsiveness of cholesterol-modified platelets.

N Tandon, J T Harmon, D Rodbard, G A Jamieson.   

Abstract

The microviscosity of human platelet membranes was changed by incubating platelets with liposomes containing various ratios of cholesterol and lecithin. Binding of 125I-thrombin to the modified platelets was measured together with platelet aggregation and secretion. In cholesterol-normal platelets (mole ratio of cholesterol to phospholipid (C:PL) = 0.553; eta = 2.40 poise), weighted nonlinear least squares curve fitting indicated that a model involving two classes of sites was adequate to describe the binding isotherm (K1 = 8.3 X 10(8) M-1; R1 = 150 sites/platelet; K2 = 6.4 X 10(6) M-1; R2 = 16,000 sites/platelet). In cholesterol-enriched platelets (C:PL = 0.857; eta = 3.05 poise), the apparent affinities for the two classes of sites decreased to 55 and 53%, respectively, while the binding capacities increased to 170 and 160%, respectively. In contrast, in the cholesterol-depleted platelets (C:PL = 0.435; eta = 2.03 poise), the affinities increased to 220 and 180%, respectively, while the binding capacities decreased to 53 and 46%, respectively. In cholesterol-enriched, cholesterol-normal, and cholesterol-depleted platelets, the thrombin concentrations required for half-maximal aggregation were 0.17, 0.35, and 0.52 nM, respectively, while the values for half-maximal secretion of [14C]serotonin were 0.17, 0.40, and 0.55 nM, respectively. Plots of receptor occupancy versus biological response showed that maximum response in cholesterol-enriched, cholesterol-normal, and cholesterol-depleted platelets occurred with occupancy of 30, 50, and 70% of the high affinity sites, respectively. In all three treatment groups, occupancy of 40-50 high affinity sites results in 50% aggregation. These results show that (i) modification of platelet membrane microviscosity results in changes in the number and affinity of both high and low affinity thrombin receptors, (ii) the change in receptor number rather than affinity is the determinant for platelet responsiveness, and (iii) the changes in membrane microviscosity do not appear to alter the coupling between occupied receptor and subsequent bioresponse.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311825

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Platelet activation in normo- and hyperlipoproteinemias.

Authors:  J Nimpf; H Wurm; G M Kostner; T Kenner
Journal:  Basic Res Cardiol       Date:  1986 Sep-Oct       Impact factor: 17.165

2.  Various effects of nutritional status on clinical outcomes after intracerebral hemorrhage.

Authors:  Yuji Shiga; Tomohisa Nezu; Ryo Shimomura; Kota Sato; Takahiro Himeno; Yuka Terasawa; Shiro Aoki; Naohisa Hosomi; Tatsuo Kohriyama; Hirofumi Maruyama
Journal:  Intern Emerg Med       Date:  2021-12-01       Impact factor: 5.472

3.  Thrombin-induced inositol trisphosphate production by rabbit platelets is inhibited by ethanol.

Authors:  M L Rand; J D Vickers; R L Kinlough-Rathbone; M A Packham; J F Mustard
Journal:  Biochem J       Date:  1988-04-01       Impact factor: 3.857

4.  Deficiency of LRP8 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis.

Authors:  Jason O Robertson; Wei Li; Roy L Silverstein; Eric J Topol; Jonathan D Smith
Journal:  Thromb Res       Date:  2008-08-15       Impact factor: 3.944

5.  Stimulated cholesterol-enriched platelets display increased cytosolic Ca2+ and phospholipase A activity independent of changes in inositol trisphosphates and agonist/receptor binding.

Authors:  A Sorisky; G L Kucera; S E Rittenhouse
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

6.  Interaction of human platelets with laminin and identification of the 67 kDa laminin receptor on platelets.

Authors:  N N Tandon; E A Holland; U Kralisz; H K Kleinman; F A Robey; G A Jamieson
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

7.  Tissue plasminogen activator promotes platelet disaggregation in plasma.

Authors:  J Loscalzo; D E Vaughan
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

Review 8.  Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies.

Authors:  Ying Rong; Li Chen; Tingting Zhu; Yadong Song; Miao Yu; Zhilei Shan; Amanda Sands; Frank B Hu; Liegang Liu
Journal:  BMJ       Date:  2013-01-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.